Lessons Learned in Elimination Campaigns for Other Diseases Curso de actualización "Eliminación de la Malaria en Mesoamérica y la Española“ CC Campbell.

Slides:



Advertisements
Similar presentations
UNDP RBA MDG-Based National Planning Workshop
Advertisements

Polio Communication Indicators Reflections from Polio Communication TAG/Review Process.
Diseases without borders What must the Global Development Community Do? World Bank Seminar Series Tawhid Nawaz, Operations Advisor Human Development Network.
Global Measles and Rubella Strategic Plan
Parasitic diseases: current and future challenges Data Source: Moran M, Guzman J, Abela Oversteegen L, Liyanage R, Omune B, Wu L, Chapman N, Gouglas D.
Celebrating Achievements
22-24 November 2011 Community Engagement for Malaria Elimination Workshop Centara Duangtawan Hotel, Chiang Mai, Thailand.
The U.S. President’s Emergency Plan for AIDS Relief The Evolving HIV Prevention Strategy for IDUs in PEPFAR Amb. Eric Goosby US Global AIDS Coordinator.
Malaria Elimination in Zanzibar. Introduction Dramatic declines in malaria morbidity and mortality over the last decade (prevalence remained
Working Together to Improve Global Health
APPMG World Malaria Day Event, 2013 Invest in The Future: Defeat Malaria Kolawole Maxwell, Malaria Consortium Nigeria Country Director.
Malaria in Zambia A refresher Scope of Presentation  Background on Malaria  Overview of malaria in Zambia  Interventions  Impact  Active Case.
Geographic Factors and Impacts: Malaria IB Geography II.
AusAID’s approach to health in developing countries
Technical Advisory Group meeting, WHO/WPRO
Regional initiative to sustain country achievement SEAR Krongthong Thimasarn Regional Adviser, Malaria World Health Organization Regional Office for South-
Economics of Malaria Liberia First July The Transparency and Accountability Network Slide 1.
Combining Entomological, Epidemiological, and Space Mapping data for Malaria Risk-mapping in Northern Uganda Findings and Implications Ranjith de Alwis,
NTDs and eye health: lessons learnt and opportunities for collaboration Adrian D Hopkins Director: Mectizan Donation Program Task Force for Global Health.
Kevin Fenton, MD, PhD, FFPH Director, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Centers for Disease Control and Prevention.
Progress in Reaching GMAP targets in India National Vector Borne Disease Control Programme India.
1 Eritrea National Malaria Control Program: On the road to malaria eradication Saleh Meky Minister of Health Government of Eritrea.
Departmental Perspectives on Viral Hepatitis
Total health ODA commitments, US$ Billions.
NATIONAL CAPACITY FOR EVALUATION OF EVIDENCE AND DECISION-MAKING Mauro Toledo Marrelli Universidade de São Paulo.
The risk of malaria worldwide: prospects for control and elimination Bob Snow KEMRI-University of Oxford collaboration, Nairobi, Kenya
1 |1 | Key problems Neglected Tropical Diseases Hidden and silent : Key problems Complacency, lack of information and commitment Complacency, lack of information.
T HE M ULTISECTORAL A PPROACH, I NVESTMENT T HINKING AND N ATIONAL AIDS R ESPONSE C OORDINATION M ESFIN G ETAHUN & B ENJAMIN O FOSU -K ORANTENG N OVEMBER.
What is “Reaching Every District” (RED) in Immunization? A brief overview Information from the global immunization partnership presented by Lora Shimp.
Roadmap Progress Report 2011 Zambia SARN-RBM PARTNERS ANNUAL CONSULTATIVE MEETING, JULY 2011.
The Research and Development Goals of the Global Plan to Stop TB Marcos Espinal Executive Secretary.
African Business Leaders on Health: GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 11, 2010 The state of Global.
Edward J. Hoekstra, MD, MSc Edward J. Hoekstra, MD, MSc Senior Health Advisor Senior Health Advisor UNICEF HQ, New York UNICEF HQ, New York Peter Strebel,
EPIDEMIOLOGY DENGUE, MALARIA Priority Areas for Planning Dengue Emergency Response 1. Establish a multisectoral dengue action committee.
Assessing the Feasibility of Continuous Net Distribution in Kenya using Community Based Approach.
PARASITIC INFECTION. Nelson and Masters Williams, 2014.
Conclusions of the meeting and closing remarks. Chronology 1981Hepatitis B vaccine becomes available 1991World Health Assembly resolution call for the.
Containment of artemisinin resistance at the Cambodia-Thailand border Sylvia Meek, Technical Director, Malaria Consortium, CMWG Meeting 8 July 2009.
1 [INSERT SPEAKER NAME DATE & LOCATION HERE] Ethics of Tuberculosis Prevention, Care and Control MODULE 2: BACKGROUND ON TUBERCULOSIS Insert country/ministry.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
Charles Godue HR Unit, PAHO/WHO The Second Conference of Asia-Pacific Action Alliance on Human Resources for Health October 2007, Beijing, China.
The AIDS Vaccine Policy Agenda Holly J. Wong Vice President, Public Policy International AIDS Vaccine Initiative (IAVI) Vienna, Austria International AIDS.
WHO/OMS Improving and increasing investments in the health outcomes of the poor Macroeconomics and Health in context Dr. Sergio Spinaci, WHO Senegal, February.
U.S. Global Health Initiative GHI Forum with GBC Lois Quam, Executive Director May 17, 2011.
Malaria Eradication: Ethics, Autonomy, Priorities David Brandling-Bennett Deputy Director, Malaria Infectious Diseases, Global Health Program May 3, 2011.
Conclusions 3 rd Meeting of National Influenza Centres in the Western Pacific and South East Asia Regions 18 – 20 August 2009 Beijing, China.
1 Roadmap to Achieve RBM Targets Country January 2011 – December 2011 Botswana.
Unit 10 PREPARING A PLAN FOR MALARIA ELIMINATION.
Larval Source Management in Africa: Case Studies Charles M. Mbogo Kenya Medical Research Institute, Centre for Geographic Medicine Research, Kilifi.
Group B Comparison of the different types of programs.
Next-Generation LLINs: Programmatic Implications Matthew Lynch October 26, 2015.
Objectives of Lipa malaria elimination course 2014 Give an account on the historical background on malaria control and elimination, including current concepts.
Understanding the Investment Approach Faith Mamba Regional Support Team Eastern and Southern Africa.
The Bank’s Regional HIV/AIDS Strategies An Overview.
Summary of potential priority actions for CMWG Case Management Working Group Meeting 8-9 July 2009.
Malaria a story of ELIMINATION A partnership of:.
THE GLOBAL FUND SUSTAINING THE GAINS AND IMPACT Uganda November 2013.
2007 Pan American Health Organization 2004 Pan American Health Organization Malaria in the Americas: Progress, Challenges, Strategies and Main Activities.
Malaria Elimination in South East Asia Region Progress, Challenges and the Way Forward Dr. Deyer Gopinath, WHO / Thailand Dr. Leonard Ortega, WHO / SEARO.
President’s Malaria Initiative: Presentation of PMI Progress, Strategy, and Priorities: RBM CCOP Meeting September 29, 2015.
Managing Pandemics Health. Health: Managing Pandemics OUTLINE What is a pandemic? Long term disease management: Malaria Sudden pandemic outbreaks: Ebola.
World Health Organization
Outline The Global Fund Strategy emphasizes the Key Populations
Seasonal Malaria Chemoprevention: WHO Policy and Perspectives
Malaria Elimination Programme Timor Leste
Human Resource Requirements for Malaria Elimination
APPMG December 17, 2008 Presented by Dr. John P. Rumunu (MPH, MB.BS)
State of Measles Initiative Financing Partners for Measles Advocacy Meeting Washington, D.C. September 22, 2008 Andrea Gay.
Partners for Measles Advocacy—7th Annual Meeting
Len Tarivonda, Director of Public Health Ministry of Health
Presentation transcript:

Lessons Learned in Elimination Campaigns for Other Diseases Curso de actualización "Eliminación de la Malaria en Mesoamérica y la Española“ CC Campbell 17 February 2014

Onchocerciasis and Smallpox Smallpox o Successful program: global eradication o Geographic distribution at onset: global, with intensity in SE Asia and Africa o Highly effective vaccine o Eradication program last ~ 20yrs Onchocerciasis o A regional elimination program (OEPA) o Effort closing in on 20 yrs. o Program based on highly efficacious drug the kills parasite and sterilizes female worms

Lessons Learned, Big Picture Operational feasibility: Establish proof at onset in range of difficult settings Subnational leaders: Establish mechanisms to understand and engage them Research: Sustain intensive program throughout initiative Insecurity and conflict: Ensure program capacity to adapt over range of settings Weak health systems: Sustain gains by addressing system vulnerabilities

Onchocerciasis: the Basics Biology-Epidemiology o Filarial worm transmitted by a biting blood-sucking insect o Adults live for 8+ yrs. o Distribution around running water…small streams up to small rivers…generally remote areas and populations o Disease manifestations are skin and eye disease…..leading to blindness o 123 million persons at risk for infection in 38 endemic countries, 25.7 million are infected, and 1 million are blinded or have severe visual impairment Intervention o Ivermectin is unique drug: kills microfilariae, sterilizes adult females o No drug resistance to date

Onchocerciasis Global Distribution

Onchocerciasis Elimination in Middle America

Onchocerciasis The Worms and the Vector

Elimination Program Ivermectin killing microfilaria up to 6 months Adult worms produce mf for 5+ yrs. Program: surveillance for eye disease, skin biopsy o MDA, high coverage at 6 mo. interval o Stratification by prevalence intensity In 2013, only 4% (23,378) of the 560,911 persons originally at risk in the Americas will be under Ivermectin MDA

Lessons Being Learned Is the eradication program purposefully vertical Develop broad range of partnerships The importance of advocacy Keep investing in intervention science Involve community-based partners Fix target and dates, but be flexible The “end-game” will be most challenging

Smallpox Historical Lessons in Eradication

Smallpox History and Epidemiology Highly transmissible: human-human Major and minor variants: major high case fatality rate Vaccination highly efficacious in producing sterilizing immunity for multiple years Global outbreaks and endemic transmission up to 1950s WHO and CDC commitment to eradication in 1967

Vaccination: The Silver Bullet

Eradication Strategy Mass vaccination with high population coverage (> 90%) Quarantine Ring vaccination and containment

Eradication Strategy Favorable Factors Highly effective intervention Lag between exposure and disease onset: vaccination effective in interval Few competing global campaigns Interventions relatively inexpensive: lives saved, deaths averted Planning projected time-limited effort

Smallpox Eradication A 20-year Global Campaign

Smallpox Eradication Results are Clear Last case 1979….in Horn of Africa Lessons learned: o Highly efficacious vaccine and favorable epidemiology o Massive effort and team work o Sustaining resources “Begin where you will end up”

Lessons Learned from Earlier Malaria Eradication Campaigns Curso de actualización: "Eliminación de la Malaria en Mesoamérica y la Española“ CC Campbell 17 February 2014

Lessons Learned from Earlier Malaria Eradication Campaigns Eliminating or eradicating malaria transmission has long history o Draining Pontine swamps to rid Rome of malaria o Malaria naturally receded in many areas of northern Europe and the United States without direct interventions; due to improved housing, etc. o An understanding of transmission intensity evolved intuitively, leading to understanding of malaria at the fringes o By mid-1900s malaria distribution and burden at historical levels

Malaria Distribution as of 1950

Technology Infused Hope for Eradication Discovery of DDT and chloroquine and wide- spread deployment opened consideration of elimination Early successes in several areas with low transmission: IRS and various uses of chloroquine (ACD, MDA, etc.) By 1957 WHO launched malaria eradication effort using IRS with various insecticides: strategy “simple”….high population coverage sustained for multiple years though undefined

The Interventions

“Global” Malaria Eradication Program Led by WHO Focus on Central America, SE Asia western Pacific, middle East IRS and drug use in various modalities Creation of national malaria eradication programs….vertical units in governments Funding USG, World Bank, and other bilaterals

Malaria Eradication: Outcomes In geographically isolated settings elimination achieved: e.g. Sri Lanka, Middle East Program named “global”, yet did not include Africa where 90% of burden exists In broader areas variable control achieved Resistance to insecticides and drugs evolved Political and financial support proved difficult to sustain Closed down 1972

District-based Action District engaged, responsible and supported A ‘Team’ approach from district to community System to map, identify coverage, gaps, & fill gaps, locate infections System to identify and treat all infections and aggressively reduce transmission Active case & infection detection Screen and treat (mass drug administration ?) Treatment for Transmission Reduction (reaching all infected people) Surveillance as an Intervention ­Identify & cure all infections (diagnosis is critical) ­Investigate and eliminate transmission (follow up is critical)

Focus on Central America, El Salvador A Personal Recounting

El Salvador …..a Malaria Success Story

Malaria El Salvador, 1974-mid 1980s Post eradication ~800,000/annually Largely focused around littoral, large-scale agriculture with irrigation(cotton, cane), and seasonal migrant labor ….the Perfect Storm Massive agricultural insecticide application Laborers from highlands; influx during rainy season Esteros filled with rain run-off…breeding sites Malaria program moved to more expensive and toxic insecticides

Malaria El Salvador 1980s-present The critical development: land reform and break up of hacienda system Combined with large projects to break up water impoundment, and dramatic drop in insecticide use No longer seasonal influx of labor 2012 reported cotton production and malaria cases….

Malaria El Salvador Cause and Effect

The Success of an Elimination Program Depends on Key Components….and Commitment and Financing TOOLS HEALTH SYSTEM ENVIRONMENT Drugs and Insecticides remain effective LLINs are used by > 80% even in the absence of malaria in the community Universal Access to High Quality Diagnosis and Treatment Near perfect surveillance (passive case detection) Strong political support Community Involvement and buy-in Resistance Monitoring and Entomological Surveillance IEC/BCC Existing plans to strengthen the health system are executed (free malaria treatment for all) QA/QC, training, health worker incentives (?), IEC/BCC High level political involvement IEC/BCC

Prevention of Reintroduction is the Challenge The Zanzibar Experience Before any prevention measures can be scaled back, surveillance must be (near) perfect! Surveys on the ferry boats and at “informal” landing sites: -Where are people coming from and where are they going? -How long are they staying for? -What is the Infection Prevalence in travelers? Border Screening? Prophylaxis in travelers/migrant workers? Screening of high risk groups?

Lessons to be Learned…..are we Listening? Elimination and eradication are serious long-term commitments Time is of the essence….resistance and boredom can eventually undo the effort A continuing portfolio of impressive successes is essential Financing will never be enough and will be required for longer that we can ever anticipate Technical contingencies and innovations must continue to evolve Start where you will end up!